Digital R&D Solutions for a Safe and Productive Return to the Lab
As COVID lockdowns end, scientists returning to the lab face new challenges. Digital R&D technology such as software and lab automation offer solutions.
As COVID lockdowns end, scientists returning to the lab face new challenges. Digital R&D technology such as software and lab automation offer solutions.
Describes new search features on BenchSci, latest search improvements and examples.
So you’ve been coming to BenchSci when you need to find an antibody to use in your experiment, but have you considered all of the other neat ways you can leverage the data on the platform? This article shows you how scientists are using the BenchSci platform in novel and innovative ways to gain competitive insights and speed up their research projects.
New technologies are flipping traditional antibody-based assays on their heads. These immunoassays are quicker, more sensitive, can be conducted high-throughput, and require minimal sample. It’s an exciting time to be a bench scientist!
Much of neuroscience research efforts has been devoted to Alzheimer’s Disease. Here we summarize what is currently known about the biomarkers for Alzheimer’s.
In this article, we describe a novel single-cell 16-plexed method to evaluate potential therapeutic efficacy of pre-infusion CD19 CART-T products.
Finding the right biological reagents for your experiment is no easy task. We discuss why and how electronic research tools can help.
Almost all biomedical research scientists use antibodies at some point. Knowing how they were generated is critical in the selection of antibodies for your experiments. Read on to find out more.
What are Innate Lymphoid Cells (ILCs)? Here we summarize the different subtypes, how to characterize them, their functions, and a list of published antibodies to study ILCs.
Proximity Extension Assay was recently shown to be an ideal proteomic approach for establishing biomarker signatures in the clinical settings. Read on the find out detailed protocol for PEA.